Amazon cover image
      Image from Amazon.com
      Image from Google Jackets

      FDA Bioequivalence Standards [electronic resource] / edited by Lawrence X. Yu, Bing V. Li.

      Contributor(s): Material type: TextTextSeries: AAPS Advances in the Pharmaceutical Sciences Series ; 13Publisher: New York, NY : Springer New York : Imprint: Springer, 2014Description: XIII, 465 p. 58 illus., 26 illus. in color. online resourceContent type:
      • text
      Media type:
      • computer
      Carrier type:
      • online resource
      ISBN:
      • 9781493912520
      Subject(s): Additional physical formats: Printed edition:: No titleDDC classification:
      • 615.19 23
      LOC classification:
      • RS380
      • RS190-210
      Online resources:
      Contents:
      1 Bioequivalence History -- 2 Fundamentals of Bioequivalence -- 3 Basic Statistical Considerations -- 4 The Effects of Food on Drug Bioavailability and Bioequivalence -- 5 Bio waiver and Biopharmaceutics Classification System -- 6 Bioequivalence of Highly Variable Drugs -- 7 Partial Area under the Curve: An Additional Pharmacokinetic Metric for Bioavailability and Bioequivalence Assessments -- 8 Bioequivalence for Narrow Therapeutic Index Drugs -- 9 Pharmacodynamic Endpoint-based Bioequivalence Studies -- 10 Clinical Endpoint Bioequivalence Study -- 11 Bioequivalence for Liposomal Drug Products -- 12 Bioequivalence for Drug Products Acting Locally within Gastrointestinal Tract -- 13 Bioequivalence for Topical Drug Products -- 14 Bioequivalence for Orally Inhaled and Nasal Drug Products -- 15 Bioequivalence: Modeling and Simulation -- 16 Bioanalysis.
      In: Springer eBooksSummary: This comprehensive reference provides an in-depth discussion on state-of-the-art regulatory science in bioequivalence. In sixteen chapters, the volume explores a broad range of topics pertaining to bioequivalence, including its origin and principles, statistical considerations, food effect studies, conditions for waivers of bioequivalence studies, Biopharmaceutics Classification Systems, Biopharmaceutics Drug Disposition Classification System, bioequivalence modeling/simulation, and best practices in bioanalysis. It also discusses bioequivalence studies with pharmacodynamic and clinical endpoints as well as bioequivalence approaches for highly variable drugs, narrow therapeutic index drugs, liposomes, locally acting gastrointestinal drug products, topical products, and nasal and inhalation products. FDA Bioequivalence Standards is written by FDA regulatory scientists who develop regulatory policies and conduct regulatory assessment of bioequivalence. As such, both practical case studies and fundamental science are highlighted in these chapters. The book is a valuable resource for scientists who work in the pharmaceutical industry, regulatory agencies, and academia as well as undergraduate and graduate students looking to expand their knowledge about bioequivalence standards.
      Tags from this library: No tags from this library for this title. Log in to add tags.
      Star ratings
          Average rating: 0.0 (0 votes)
      Holdings
      Item type Current library Call number URL Status Notes Date due Barcode
      e-Books e-Books SARVAJNA LIBRARY, UHS, BAGALKOT 615.19 (Browse shelf(Opens below)) Link to resource Available Click on the URL to access eBook EB683

      1 Bioequivalence History -- 2 Fundamentals of Bioequivalence -- 3 Basic Statistical Considerations -- 4 The Effects of Food on Drug Bioavailability and Bioequivalence -- 5 Bio waiver and Biopharmaceutics Classification System -- 6 Bioequivalence of Highly Variable Drugs -- 7 Partial Area under the Curve: An Additional Pharmacokinetic Metric for Bioavailability and Bioequivalence Assessments -- 8 Bioequivalence for Narrow Therapeutic Index Drugs -- 9 Pharmacodynamic Endpoint-based Bioequivalence Studies -- 10 Clinical Endpoint Bioequivalence Study -- 11 Bioequivalence for Liposomal Drug Products -- 12 Bioequivalence for Drug Products Acting Locally within Gastrointestinal Tract -- 13 Bioequivalence for Topical Drug Products -- 14 Bioequivalence for Orally Inhaled and Nasal Drug Products -- 15 Bioequivalence: Modeling and Simulation -- 16 Bioanalysis.

      This comprehensive reference provides an in-depth discussion on state-of-the-art regulatory science in bioequivalence. In sixteen chapters, the volume explores a broad range of topics pertaining to bioequivalence, including its origin and principles, statistical considerations, food effect studies, conditions for waivers of bioequivalence studies, Biopharmaceutics Classification Systems, Biopharmaceutics Drug Disposition Classification System, bioequivalence modeling/simulation, and best practices in bioanalysis. It also discusses bioequivalence studies with pharmacodynamic and clinical endpoints as well as bioequivalence approaches for highly variable drugs, narrow therapeutic index drugs, liposomes, locally acting gastrointestinal drug products, topical products, and nasal and inhalation products. FDA Bioequivalence Standards is written by FDA regulatory scientists who develop regulatory policies and conduct regulatory assessment of bioequivalence. As such, both practical case studies and fundamental science are highlighted in these chapters. The book is a valuable resource for scientists who work in the pharmaceutical industry, regulatory agencies, and academia as well as undergraduate and graduate students looking to expand their knowledge about bioequivalence standards.

      There are no comments on this title.

      to post a comment.
      External Imp. Links

      UHSB || ICAR || IDEAL: A Union Catalog of NARS Libraries || KrushiKosh (Digital Library) || Kanaja (ಕಣಜ – ಕನ್ನಡ ಜ್ಞಾನಕೋಶ) || Karnataka Gazetteer || ASRB || Employment News || ಉದ್ಯೋಗ ಮಾಹಿತಿ || || Karnataka Digital Public Library ||


      For more Information please contact Librarian @ Sarvajna Library, UHS, Bagalkot OR Dr. Gireesh A Ganjihal Assistant Librarian
      "Healthy Soils for a Healthy Life"

      page counter